Venture Certified
| 연구개발유형 | 2024-04-29 ~ 2027-04-28 | 20240429020004 | 2024-04-29 |
Revenue CAGR +292.9%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 6.1B | 1.6B | 0.0B |
| Operating Profit | 0.1B | -0.3B | -1.8B |
| Net Profit | 0.1B | 0.0B | -1.8B |
| Total Assets | 22.5B | 17.4B | 18.3B |
| Total Liabilities | 11.7B | 6.7B | 7.6B |
| Total Equity | 10.8B | 10.7B | 10.7B |
Debt Ratio Surge (+45pp YoY)
▲ 685.7%
▲ 108.2%
▲ 106.7%
▲ 60.4%
▲ 111.9%
| Name | Position | Role |
|---|---|---|
| 정해준, DANIEL NAM CHON | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "대구광역시 달서구",
"ceo_name": "정해준, DANIEL NAM CHON",
"certificate": [
{
"cert_number": "20240429020004",
"changes": "",
"disclosure_date": "2024-04-29",
"first_cert_date": "2024-04-29",
"no": "1",
"type": "연구개발유형",
"valid_period": "2024-04-29 ~ 2027-04-28"
}
],
"company_name": "(주)씨티엘바이오테크",
"corp_no": "170111-*******",
"financials": {
"2022": {
"capital_stock": 57000000,
"cost_of_sales": 0,
"current_assets": 1429626000,
"current_liabilities": 763359000,
"gross_profit": 0,
"net_income": -176435000,
"net_income_bs": -176435000,
"non_current_assets": 401414000,
"non_current_liabilities": 0,
"non_operating_expenses": 2089000,
"non_operating_income": 1250000,
"operating_profit": -175596000,
"revenue": 0,
"sga_expenses": 175596000,
"total_assets": 1831040000,
"total_equity": 1067681000,
"total_liabilities": 763359000
},
"2023": {
"capital_stock": 57000000,
"cost_of_sales": 122685000,
"current_assets": 1118106000,
"current_liabilities": 672621000,
"gross_profit": 32626000,
"net_income": 3573000,
"net_income_bs": 3573000,
"non_current_assets": 625770000,
"non_current_liabilities": 0,
"non_operating_expenses": 1105000,
"non_operating_income": 37247000,
"operating_profit": -32569000,
"revenue": 155311000,
"sga_expenses": 65195000,
"total_assets": 1743876000,
"total_equity": 1071255000,
"total_liabilities": 672621000
},
"2024": {
"capital_stock": 57000000,
"cost_of_sales": 552680000,
"current_assets": 1613620000,
"current_liabilities": 1165014000,
"gross_profit": 57490000,
"net_income": 10412000,
"net_income_bs": 10412000,
"non_current_assets": 633060000,
"non_current_liabilities": 0,
"non_operating_expenses": 12390000,
"non_operating_income": 14254000,
"operating_profit": 8548000,
"revenue": 610170000,
"sga_expenses": 48942000,
"total_assets": 2246680000,
"total_equity": 1081666000,
"total_liabilities": 1165014000
}
},
"industry": "정형외과용 및 신체보정용 기기 제조업",
"investment": [],
"main_products": "정형외과용 의료기기",
"phone": "053-591-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |